A PYMNTS Company

EU: Acquisition of Perrigo by Mylan cleared

By  |  July 29, 2015

The European Commission said on Wednesday it had cleared generic drug maker Mylan’s planned takeover of Ireland-based Perrigo Co.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The Commission said in a statement that the proposed acquisition would not raise competition concerns, because the parties’ activities are largely complementary, Mylan being one of the main European producers of prescribed generic drugs and Perrigo specialised in selling over-the-counter drugs.

    Mylan had been at the centre of a three-way takeover battle, with Perrigo having rejected a sweetened $34 billion offer, and Mylan seeking to fend off a takeover by Israel-based Teva Pharmaceutical Industries, the world’s largest generic drug maker.

    Full content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.